FILGRASTIM POSTCHEMOTHERAPY MOBILIZES MORE CD34(-STATE HEMATOPOIESIS (VOL 14, PG 827, 1994)() CELLS WITH A DIFFERENT ANTIGENIC PROFILE COMPARED WITH USE DURING STEADY)
R. Mohle et al., FILGRASTIM POSTCHEMOTHERAPY MOBILIZES MORE CD34(-STATE HEMATOPOIESIS (VOL 14, PG 827, 1994)() CELLS WITH A DIFFERENT ANTIGENIC PROFILE COMPARED WITH USE DURING STEADY), Bone marrow transplantation, 15(4), 1995, pp. 655-655